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A B S T R A C T
A 60-year-old lady presented to the emergency room with breathlessness, palpitations, 
dizziness and hypotension. The ECG showed narrow QRS complex tachycardia at a 
rate of 300 beats/min and downsloping ST-segment depression. Following intravenous 
administration of adenosine, atrial flutter was confirmed and due to hemodynamic in-
stability a direct current shock was delivered which restored sinus rhythm. The causes 
of such rapid ventricular rates in atrial flutter are discussed a propos with this case 
report.
I N T R O D U C T I O N
Atrial flutter with 1:1 atrioventricular (AV) conduction is commonly encountered 
in patients receiving class I antiarrhythmic drugs, like propafenone, disopyramide or 
quinidine, without concomitant intake of AV node blocking agents.1 On the other 
hand, this phenomenon is only rarely observed in patients not receiving this type of 
antiarrhythmic medications.2 Moreover, ST-segment depression is frequently observed 
during paroxysmal supraventricular tachycardias and there are clinical studies show-
ing no association with coronary heart disease.3 We describe a case of a middle-aged 
woman who developed atrial flutter with 1:1 AV conduction and marked ST-segment 
depression on the surface electrocardiogram (ECG). 
C A S E  R E P O R T
A 60–year–old lady presented to the emergency room with breathlessness, palpita-
tions, dizziness and hypotension with a systolic blood pressure of 80 mm Hg. Symptoms 
started around three to four hours earlier and over the last one hour prior to admission 
the patient also developed chest discomfort. She had no history or clinical evidence of 
coronary artery disease, pericardial, myocardial or valvular disease and she was not 
receiving any antiarrhythmic or antihypertensive drugs. The ECG showed narrow QRS 
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complex tachycardia at a rate of 300 beats per minute (bpm) 
with 2 mm downsloping ST-segment depression in leads I, II, 
III, aVF, V2 – V6 and 1 mm ST elevation in leads aVL and 
aVR (Fig. 1A). Following intravenous administration of 12 
mg of adenosine, atrial flutter with rate of 300 bpm was noted 
(Fig. 1B). As the patient was hemodynamically unstable, a 
direct current shock at 70 Joules was delivered with successful 
conversion of the arrhythmia into sinus rhythm. The post-
conversion ECG revealed a short PR interval (Fig. 1C); no 
previous ECG recording was available for comparison. After 
cardioversion the patient’s blood pressure was stabilized and 
the symptoms abated.
One hour later, the ST segment deviation returned to 
normal (Fig. 1D), while the PR interval was persistently short. 
Furthermore, myocardial enzymes were normal. Cardiac 
ultrasound revealed no underlying cardiac abnormalities and 
the thyroid function tests were normal excluding hyperthyroid-
ism. In order to rule out coronary heart disease, myocardial 
scintigraphy was performed 24 hours later. No evidence of 
myocardial ischemia was detected. The patient refused an 
electrophysiological study and she was discharged on medical 
therapy with beta – blocker plus diltiazem.
D I S C U S S I O N
Atrial flutter is a relative common arrhythmia in the gen-
eral population characterized by an organized atrial rhythm 
with a rate typically between 250 and 350 bpm. Electrophysi-
ological studies have shown that this simple ECG definition 
includes tachycardias using a variety of macro-reentry circuits. 
The usual ventricular response in atrial flutter is about 150 bpm 
(due to 2:1 AV conduction).4 However, under special circum-
stances, a 1:1 AV conduction has been noted, leading to rapid 
heart rates (up to 300 bpm) with hemodynamic consequences 
like syncope, hemodynamic collapse, angina pectoris, acute 
FIgURE 1. A. The presenting ECG of the patient. B. Continuous recording of limb leads during adenosine administration reveals 
atrial flutter waves. C. Normal sinus rhythm after the DC shock. D. ECG one hour after the restoration of normal sinus rhythm.
RAPID ATRIAL FLuTTER
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pulmonary edema and even sudden death, depending on the 
cardiac status of the individual patient.1
This phenomenon has been noted since the 1950s in pa-
tients treated with a class I antiarrhythmic drug, in patients 
with Wolff-Parkinson-White syndrome with an accessory AV 
pathway bypassing the AV node and capable of rapid AV con-
duction, in hyperthyroidism, and in children.5,6 It seems that a 
preexisting rapid AV nodal conduction could be a predisposing 
factor for the occurrence of a 1:1 AV conduction during atrial 
flutter in some patients. The presence of a short PR interval 
indicating enhanced AV nodal conduction on the surface ECG 
is a simple means to identify this characteristic.7 The increased 
P wave duration has also been associated with atrial arrhyth-
mias.8 Rarely, has this degree of rapid ventricular response 
been reported in the absence of antiarrhythmic drug therapy 
or in patients with enhanced AV nodal conduction properties, 
previously termed the Lown-Ganong-Levine syndrome.2 In a 
retrospective study published by Kawabata et al, all patients 
who were suffering from atrial flutter with 1:1 AV conduction 
were receiving a class Ia, Ic or III antiarrhythmic drug and they 
had a significantly longer atrial flutter cycle length and more 
rapid AV nodal conduction time compared with those with 
atrial flutter without 1:1 AV conduction.9
In our patient, atrial flutter with 1:1 AV conduction was 
not associated with any apparent cause. Moreover, during 
the tachycardia remarkable ST-segment depression was 
noted without underlying true ischemia as evidenced by the 
absence of cardiac enzyme elevation and negative myocardial 
scintigraphy, essentially ruling out any significant underlying 
coronary heart disease. ST-segment depression is frequently 
observed during episodes of paroxysmal supraventricular 
tachycardias. From previous clinical studies it has been sug-
gested that coronary artery disease is one but not the only 
mechanism causing these ECG repolarization abnormalities. 
Petsas et al performed an exercise treadmill stress test in 16 
patients with noticeable ST segment depression during supra-
ventricular tachycardia and they found that 94% of patients 
had no evidence of coronary artery disease.10 Moreover, Lin 
et al examined 51 patients with narrow QRS supraventricular 
arrhythmias and found that 51% of them developed repolar-
ization changes during the tachycardia without evidence of 
coronary heart disease.3 In a prospective study, Androulakis 
et al did not find any strong association between transient isch-
emic type ST-segment depression during paroxysms of atrial 
fibrillation and underlying occult coronary artery disease.11
In conclusion, atrial flutter with 1:1 AV conduction must 
be suspected in case of a narrow QRS complex tachycardia 
with extremely rapid ventricular rate even in the absence of 
any antiarrhythmic drug intake. As atrial flutter is a macro-
reentrant tachycardia, radiofrequency catheter ablation may 
be considered to be an appropriate therapeutic modality,4 
especially in patients with 1:1 AV conduction who cannot toler-
ate this rapid rhythm and present with syncope or presyncope 
and associated hemodynamic collapse.
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